SCHEMBL2297835

SCHEMBL2297835

CN(C)C1CCN(Cc2ccc(-c3nc4c(C(N)=O)cccc4[nH]3)c(F)c2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 18/20 0.53
PARP2 Q9UGN5 3/20 0.53
MAP4K4 O95819 2/20 0.52
CSF1R P07333 2/20 0.52
PIM1 P11309 2/20 0.52
CLK2 P49760 2/20 0.52
MAP4K2 Q12851 2/20 0.52
DYRK1A Q13627 2/20 0.52
MINK1 Q8N4C8 2/20 0.52
AURKB Q96GD4 2/20 0.52
MAP4K5 Q9Y4K4 2/20 0.52
DYRK3 O43781 1/20 0.52
PRKD3 O94806 1/20 0.52
INSR P06213 1/20 0.52
IRAK1 P51617 1/20 0.52
PRKCD Q05655 1/20 0.52
MELK Q14680 1/20 0.52
PRKD2 Q9BZL6 1/20 0.52
CLK4 Q9HAZ1 1/20 0.52
IRAK4 Q9NWZ3 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2297309 0.89 PARP1 (0.56) PARP1PARP2MAP4K4CSF1RPIM1
SCHEMBL2294477 0.86 PARP1 (0.69) PARP1PARP2AURKBDHODH
SCHEMBL2296206 0.81 PARP1 (0.57) PARP1PARP2MAP4K4CSF1RPIM1
SCHEMBL2291944 0.78 PARP1 (0.56) PARP1PARP2MAP4K4CSF1RPIM1
SCHEMBL2291954 0.78 PARP1 (0.56) PARP1PARP2MAP4K4CSF1RPIM1
SCHEMBL2295799 0.78 PARP1 (0.56) PARP1PARP2MAP4K4CSF1RPIM1
SCHEMBL2298424 0.78 PARP1 (0.54) PARP1PARP2MAP4K4CSF1RPIM1
SCHEMBL2294134 0.78 PARP1 (0.54) PARP1PARP2MAP4K4CSF1RPIM1
SCHEMBL4970499 0.77 MAP4K4 (0.68) PARP1PARP2MAP4K4CSF1RPIM1
SCHEMBL2298581 0.77 PARP1 (0.71) PARP1PARP2AURKBDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999117-B2 Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors ABBVIE INC. 2011-08-16 US claimed
US-20090186877-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS ABBOTT LABORATORIES (US) 2009-07-23 US claimed
US-20070259937-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS ABBOTT LABORATORIES 2007-11-08 US claimed
US-7999117-B2 Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors ABBVIE INC. 2011-08-16 US disclosed
US-20090186877-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS ABBOTT LABORATORIES (US) 2009-07-23 US disclosed
US-20070259937-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS ABBOTT LABORATORIES 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259937-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS PARP1, PARP2, PARP4 PARP1 1/4885PARP2 2/4885MAP4K4 1035/4885
US-20090186877-A1 SUBSTITUTED 1H-BENZIMIDAZOLE-4-CARBOXAMIDES ARE POTENT PARP INHIBITORS PARP1, PARP2, PARP4 PARP1 1/4885PARP2 2/4885MAP4K4 1035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.